EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A novel peptide targeting CCR7 inhibits tumor cell lymph node metastasis

Yixuan Sun, Yuzhen Qian, Lu Qiu, Xueqin Zhu, Haoming Ning, Liwei Pang, Xiaoshuang Niu, Yi Liu, Xiuman Zhou, Guanyu Chen, Wenjie Zhai, Yanfeng Gao

Cancer Immunology, Immunotherapy · 2025

DOI: 10.1007/s00262-025-03995-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Yixuan Sun und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, China. Hauptthemen laut MEDLINE: Receptors, CCR7, Lymphatic Metastasis, Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Fundamental Research Funds for the Central Universities, Sun Yat-sen University, Shenzhen Science and Technology Program, The "Pearl River Talent Plan" Innovation and Entrepreneurship Team Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymph nodes are the most common metastasis sites for tumor cells, which are intimately linked to patient prognosis. It has been reported that cancer cells can upregulate CC Chemokine Receptor 7 (CCR7) expression and hijack its normal functions, enabling them to migrate along the gradient of CCL19 and CCL21 toward the lymph nodes and colonies as the initial stage of distant metastasis. In tumor patients, the metastatic tumor in the lymph nodes exhibited higher expression of CCR7, as well as inhibitory immune checkpoints PD-1, LAG-3, and TIM-3 compared to the primary tumors with the analysis of TCGA and GEO databases. Also, in mouse tumor model, tumor cells with elevated CCR7 expression were more susceptible to develop popliteal lymph node metastasis. Subsequently, we successfully identified a CCR7 binding peptide TC6 by phage display biopanning, which specifically blocks the interaction of CCR7/CCL19 and CCR7/CCL21. Further, the D-amino acids were introduced to substitute the N- and C-terminus of TC6 peptide to obtain the proteolysis-resistant TC6-D3 peptide, which decreased tumor cell migration in vitro via ERK1/2 pathway and inhibited tumor growth and lymph nodes metastasis in vivo, as well as effectively restored T cells cytotoxicity in both primary tumors and lymph nodes. In conclusion, CCR7 promoted tumor cell metastasis to lymph node and inhibited the anti-tumor immune responses in lymph nodes. Specific blockade of the CCR7 pathway with TC6-D3 peptide can significantly reduce lymph node tumor burden, promoting CD8 + T cell infiltration in primary tumors, meanwhile, enhancing anti-tumor immune responses in lymph nodes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CCR7Lymphatic MetastasisPeptidesAnimalsHumansMiceFemaleCell MovementLymph NodesCell Line, TumorChemokine CCL19Mice, Inbred BALB CChemokine CCL21

Stichwörter der Autor:innen

BlockadeCCR7Immune responsesLymph node metastasisPeptide

Substanzen

Receptors, CCR7CCR7 protein, humanPeptidesChemokine CCL19Chemokine CCL21

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, China.
  • School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.
  • School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China. wjzhai@zzu.edu.cn.
  • School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, China. gaoyf29@mail.sysu.edu.cn.

Förderung

  • The Fundamental Research Funds for the Central Universities, Sun Yat-sen University
  • Shenzhen Science and Technology Program
  • The "Pearl River Talent Plan" Innovation and Entrepreneurship Team Project of Guangdong Province
  • The Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Sun, Y., Qian, Y., Qiu, L., Zhu, X., Ning, H., Pang, L., Niu, X., Liu, Y., Zhou, X., Chen, G., Zhai, W., & Gao, Y. (2025). A novel peptide targeting CCR7 inhibits tumor cell lymph node metastasis. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-03995-4

Vancouver

Sun Y, Qian Y, Qiu L, Zhu X, Ning H, Pang L, et al. A novel peptide targeting CCR7 inhibits tumor cell lymph node metastasis. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-03995-4

BibTeX
@article{Sun2025,
  author = {Sun, Yixuan and Qian, Yuzhen and Qiu, Lu and Zhu, Xueqin and Ning, Haoming and Pang, Liwei and Niu, Xiaoshuang and Liu, Yi and Zhou, Xiuman and Chen, Guanyu and Zhai, Wenjie and Gao, Yanfeng},
  title = {A novel peptide targeting CCR7 inhibits tumor cell lymph node metastasis},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  doi = {10.1007/s00262-025-03995-4}
}
Kostenlos starten →